Ozmosi | Methoxyphenamine Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Methoxyphenamine

Alternative Names: methoxyphenamine
Clinical Status: Inactive
Latest Update: 2025-08-05
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRB Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Chile | Hong Kong | Ireland | Korea | New Zealand | Peru | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Shanghai Changzheng Hospital
Company Location: Asia Pacific
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ChiCTR2400081693

ChiCTR2400081693

N/A

Not yet recruiting

Unknown

2025-12-31

2024-03-08

Treatments

ChiCTR2300070364

ChiCTR2300070364

N/A

Recruiting

Drug Hypersensitivity

2024-03-26

2023-06-09

Treatments

ChiCTR-IOR-15007571

ChiCTR-IOR-15007571

N/A

Not yet recruiting

Chronic Obstructive Pulmonary Disease

2016-03-01

ChiCTR-ONC-13003067

ChiCTR-ONC-13003067

N/A

Completed

Chronic Cough

2015-03-31

ChiCTR-TRC-08000152

ChiCTR-TRC-08000152

N/A

Completed

Chronic Cough

2009-06-30